Bellerophon Therapeutics, Inc. | Uncategorized | Business Contracts

Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 11, 2021)

Open Market Sale AgreementSM, dated July 17, 2020, by and between Bellerophon Therapeutics, Inc. and Jefferies LLC (Filed With SEC on July 17, 2020)

Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 6, 2020)

Form of Engagement Letter (Filed With SEC on March 30, 2020)

Fourth Amendment to Exclusive Cross-License, Technology Transfer and Regulatory Matters Agreement, dated April 23, 2018, by and between Bellerophon Pulse Technologies LLC and INO... (Filed With SEC on April 26, 2018)

Third Amendment to Drug Clinical Supply Agreement, dated April 23, 2018, by and between Bellerophon Pulse Technologies LLC and INO Therapeutics LLC (Filed With SEC on April 26, 2018)

Form of Warrant Agreement (Filed With SEC on September 27, 2017)

Registration Rights Agreement, dated September 26, 2017, among the Registrant and the investors named therein (Filed With SEC on September 27, 2017)

Securities Purchase Agreement, dated September 26, 2017 , among the Registrant and the investors named therein (Filed With SEC on September 27, 2017)

********************* (Filed With SEC on May 12, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 12, 2017)

COMMON STOCK PURCHASE WARRANT BELLEROPHON THERAPEUTICS, INC. (Filed With SEC on May 12, 2017)

53 Frontage Road, Suite 301, Hampton, NJ 08827 l 908-574-4770 l bellerophon.com (Filed With SEC on March 16, 2017)

FORM OF COMMON STOCK PURCHASEWARRANT BELLEROPHONTHERAPEUTICS, INC. (Filed With SEC on November 21, 2016)

FORM OF SECURITIES PURCHASEAGREEMENT (Filed With SEC on November 21, 2016)

As such, SectionA.5 is hereby amended and restated in its entirety to read as follows: (Filed With SEC on November 21, 2016)

COMMON STOCK PURCHASE WARRANT BELLEROPHONTHERAPEUTICS, INC. (Filed With SEC on November 10, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 10, 2016)

430Park Avenue | New York, New York 10022 | 212.356.0500 | www.hcwco.com Member:FINRA/SIPC (Filed With SEC on November 10, 2016)

BELLEROPHON THERAPEUTICS, INC. Common Stock (par value $0.01 per share) (Filed With SEC on May 27, 2016)

Acknowledged by:/s/ Parag Shah21-Sept-2015Employee SignatureDate (Filed With SEC on May 10, 2016)

184 Liberty Corner Road, Suite 302, Warren, NJ 07059 | 908-574-4770 | bellerophon.com (Filed With SEC on March 21, 2016)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 21, 2016)

SECOND AMENDMENT TO DRUG CLINICAL SUPPLY AGREEMENT AND THIRD AMENDMENT TO EXCLUSIVE CROSS-LICENSE, TECHNOLOGY TRANSFER, AND REGULATORY MATTERS AGREEMENT (Filed With SEC on January 12, 2016)

BELLEROPHON THERAPEUTICS, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on December 4, 2015)

FIRST AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on November 12, 2015)

LEASE AGREEMENT BETWEEN 184 PROPERTY OWNER, LLC, a New Jersey limited liability company, LANDLORD, -AND- BELLEROPHON THERAPEUTICS, INC. a Delaware corporation, TENANT DATED:... (Filed With SEC on November 12, 2015)

SECOND AMENDMENT TO EXCLUSIVE CROSS-LICENSE, TECHNOLOGY TRANSFER, AND REGULATORY MATTERS AGREEMENT (Filed With SEC on November 12, 2015)

Exhibit A Form of Amendment to Non-Compete Agreements AMENDMENT TO AGREEMENT NOT TO COMPETE (Filed With SEC on November 12, 2015)

FIRST AMENDMENT TO TRANSITION SERVICES AGREEMENT (Filed With SEC on November 12, 2015)

SEVERANCE AND RELEASE AGREEMENT (Filed With SEC on November 12, 2015)

PROFESSIONAL SERVICES AGREEMENT (Filed With SEC on November 12, 2015)

53 Frontage Road, Suite 301, Hampton, NJ 08827 | 908-574-4770 | bellerophon.com (Filed With SEC on November 12, 2015)

53 Frontage Road, Suite 301, Hampton, NJ 08827 | 908-574-4770 | bellerophon.com (Filed With SEC on August 14, 2015)

53 Frontage Road, Suite 301, Hampton, NJ 08827 | 908-574-4770 | bellerophon.com (Filed With SEC on May 15, 2015)

Bellerophon Therapeutics, Inc. (71) | Uncategorized (59)